119 related articles for article (PubMed ID: 6444949)
1. Reversible modification of arginine residues in neocarzinostatin. Isolation of a biologically active 89-residue fragment from the tryptic hydrolysate.
Samy TS; Kappen LS; Goldberg IH
J Biol Chem; 1980 Apr; 255(8):3420-6. PubMed ID: 6444949
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional arginine residues in ribonuclease A and lysozyme.
Patthy L; Smith EL
J Biol Chem; 1975 Jan; 250(2):565-9. PubMed ID: 1112778
[TBL] [Abstract][Full Text] [Related]
3. Reversible modification of arginine residues. Application to sequence studies by restriction of tryptic hydrolysis to lysine residues.
Patthy L; Smith EL
J Biol Chem; 1975 Jan; 250(2):557-64. PubMed ID: 234432
[TBL] [Abstract][Full Text] [Related]
4. 1,2-Cyclohexanedione modification of arginine residues in egg-white riboflavin-binding protein.
Kozik A; Guevara I; Zak Z
Int J Biochem; 1988; 20(7):707-11. PubMed ID: 3181600
[TBL] [Abstract][Full Text] [Related]
5. Structure of the antitumor protein neocarzinostatin. Purification, amino acid composition, disulfide reduction, and isolation and composition of tryptic peptides.
Maeda H; Glaser CB; Czombos J; Meienhoffer J
Arch Biochem Biophys; 1974 Oct; 164(2):369-78. PubMed ID: 4282218
[No Abstract] [Full Text] [Related]
6. Identification of the C-1-phosphate-binding arginine residue of rabbit-muscle aldolase. Isolation of 1,2-cyclohexanedione-labeled peptide by chemisorption chromatography.
Patthy L; Váradi A; Thész J; Kovács K
Eur J Biochem; 1979 Sep; 99(2):309-13. PubMed ID: 499203
[TBL] [Abstract][Full Text] [Related]
7. Modification of arginines in bovine growth hormone.
Wolfenstein-Todel C; Santomé JA
Int J Pept Protein Res; 1983 Nov; 22(5):611-6. PubMed ID: 6317584
[TBL] [Abstract][Full Text] [Related]
8. The generalization of pre-neocarzinostatin and antagonism of neocarzinostatin-induced DNA scission in vitro.
Jung G; Lewis RS; Köhnlein W
Biochim Biophys Acta; 1980 Jun; 608(1):147-53. PubMed ID: 6446322
[TBL] [Abstract][Full Text] [Related]
9. Modification of arginine residues in human growth hormone by 1,2-cyclohexanedione: effects on the binding capacity to lactogenic and somatogenic receptors.
Atlasovich FM; Caridad JJ; Nowicki C; Santomé JA; Wolfenstein-Todel C
Arch Biochem Biophys; 1990 Aug; 281(1):1-5. PubMed ID: 2166475
[TBL] [Abstract][Full Text] [Related]
10. Preparation and properties of carp muscle parvalbumin fragments A (residues 1 leads to 75) and B (residues 76 leads to 108).
Coffee CJ; Solano C
Biochim Biophys Acta; 1976 Nov; 453(1):67-80. PubMed ID: 999890
[TBL] [Abstract][Full Text] [Related]
11. Reexamination of the primary structure of an antitumor protein, neocarzinostatin.
Kuromizu K; Tsunasawa S; Maeda H; Abe O; Sakiyama F
Arch Biochem Biophys; 1986 Apr; 246(1):199-205. PubMed ID: 2938543
[TBL] [Abstract][Full Text] [Related]
12. Arginine modification in Kunitz bovine trypsin inhibitor through 1, 2-cyclohexanedione.
Menegatti E; Ferroni R; Benassi CA; Rocchi R
Int J Pept Protein Res; 1977; 10(2):146-52. PubMed ID: 302243
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an essential arginine residue in the active site of Escherichia coli 2-keto-4-hydroxyglutarate aldolase. Modification with 1,2-cyclohexanedione.
Vlahos CJ; Ghalambor MA; Dekker EE
J Biol Chem; 1985 May; 260(9):5480-5. PubMed ID: 3886656
[TBL] [Abstract][Full Text] [Related]
14. Neocarzinostatin: effect of modification of side chain amino and carboxyl groups on chemical and biological properties.
Samy TS
Biochemistry; 1977 Dec; 16(25):5573-8. PubMed ID: 144523
[TBL] [Abstract][Full Text] [Related]
15. Determination of arginine in the reactive site of proteinase inhibitors by selective and reversible derivatization of the arginine side chain.
Dietl T; Tschesche H
Hoppe Seylers Z Physiol Chem; 1976 May; 357(5):657-65. PubMed ID: 964925
[TBL] [Abstract][Full Text] [Related]
16. Probing the active site residues in aromatic donor oxidation in horseradish peroxidase: involvement of an arginine and a tyrosine residue in aromatic donor binding.
Adak S; Mazumder A; Banerjee RK
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):985-91. PubMed ID: 8615798
[TBL] [Abstract][Full Text] [Related]
17. A revised primary structure for neocarzinostatin based on fast atom bombardment and gas chromatographic-mass spectrometry.
Gibson BW; Herlihy WC; Samy TS; Hahm KS; Maeda H; Meienhofer J; Biemann K
J Biol Chem; 1984 Sep; 259(17):10801-6. PubMed ID: 6236220
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous deamidation of a protein antibiotic, neocarzinostatin, at weakly acidic pH. Conversion to a homologous inactive preneocarzinostatin due to change of asparagine 83 to aspartic acid 83 accompanied by conformational and biological alterations.
Maeda H; Kuromizu K
J Biochem; 1977 Jan; 81(1):25-35. PubMed ID: 14934
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of D-amino acid oxidase with 1,2-cyclohexanedione: evidence for one arginine in the substrate-binding site.
Ferti C; Curti B; Simonetta MP; Ronchi S; Galliano M; Minchiotti L
Eur J Biochem; 1981 Oct; 119(3):553-7. PubMed ID: 6118269
[TBL] [Abstract][Full Text] [Related]
20. Functional arginine residues involved in coenzyme binding by glutamate dehydrogenases.
Blumenthal KM; Smith EL
J Biol Chem; 1975 Aug; 250(16):6555-9. PubMed ID: 169251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
